FDA-approved
Brain & sleep
Ziconotide
Evidence
FDA approved
Class
Synthetic version of a cone snail peptide
KEY TAKEAWAY
Ziconotide is a synthetic copy of a peptide made by the marine cone snail Conus magus. It is sold as Prialt. The FDA approved ziconotide (Prialt) in 2004 for severe chronic pain in people who need intrathecal therapy.
Written by the Veylo editorial team · Updated
November 2026
What it is
Synthetic version of a cone snail peptide
Approved for
Severe chronic pain when other treatments have failed
Key fact
The FDA approved ziconotide (Prialt) in 2004 for severe chronic pain in people who need intrathecal therapy.
Route
Continuous infusion into the spinal fluid by an implanted pump
Evidence strength
FDA approved
Ziconotide is a synthetic copy of a peptide made by the marine cone snail Conus magus. It is sold as Prialt.
It blocks N-type calcium channels on pain-sensing nerves in the spinal cord, which reduces the transmission of pain signals.
The FDA approved ziconotide (Prialt) in 2004 for severe chronic pain in people who need intrathecal therapy.
Severe chronic pain when other treatments have failed.
It can cause serious psychiatric and nervous system effects, including confusion, hallucinations and depression. The label carries a boxed warning for severe psychiatric symptoms.
U.S. FDA prescribing information for Ziconotide. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.